NCT06043284View on ClinicalTrials.gov

Study to Compare Verbal Scores of Children Diagnosed With ASD Who Received Hyperbaric Treatment To Those Who Did Not

CompletedOBSERVATIONAL
Enrollment

65

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

July 31, 2021

Study Completion Date

February 20, 2022

Conditions
Autism Spectrum Disorder
Interventions
DEVICE

Hyperbaric Oxygen Therapy

Subjects received 100% medical grade oxygen for 60 minutes at 2.0 ATA for 40 sessions in a hard-sided monoplace hyperbaric chamber

Trial Locations (2)

48084

Oxford Recovery Center, Troy

48116

Oxford Recovery Center, Brighton

All Listed Sponsors
collaborator

The Oxford Center

UNKNOWN

lead

Oxford Recovery Center

OTHER

NCT06043284 - Study to Compare Verbal Scores of Children Diagnosed With ASD Who Received Hyperbaric Treatment To Those Who Did Not | Biotech Hunter | Biotech Hunter